FDA webinar Oct. 31 on proposed rule for laboratory developed tests聽
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a to review its recent proposed rule for laboratory developed tests, which would amend the agency鈥檚 regulations to require most laboratory developed tests to meet the same medical device requirements as other in vitro diagnostic products. Participants may email questions for consideration to until Oct. 23.
Related News Articles
Headline
Despite elegant efforts to design for safe use, rigorous standards and regulatory requirements, and lots of training of health care professionals, there鈥檚鈥
Headline
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and鈥
Headline
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such as continuous glucose monitors,鈥
Headline
The Food and Drug Administration yesterday released recommendations for streamlining the approval process for medical devices that use artificial intelligence鈥
Headline
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that鈥
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of 鈥渞emanufacturing鈥 for reusable medical devices needing鈥